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Abstract: BACKGROUND Exceptional agers (85+ years) are characterized by preserved cognition pre-
sumably due to high cognitive reserve. In the current study, we examined whether personality, risk and
protective factors for dementia as well as quality of life are associated with core features of Alzheimer’s
disease (amyloid-deposition and hippocampal volume) as well as cognition in exceptional aging. METH-
ODS We studied 49 exceptional agers (average 87.8 years, range 84-94 years), with preserved activities
of daily living and absence of dementia. All participants received a detailed clinical and neuropsycholog-
ical examination. We used established questionnaires to measure lifetime experience, personality, recent
physical and cognitive activity as well as quality of life. Cerebral amyloid-deposition was estimated by
18-[F]-Flutemetamol-PET and manual hippocampal volumetry was performed on 3D T1 MRI images.
RESULTS In this sample of exceptional agers with preserved activities of daily living, we found intact
cognitive performance in the subjects with the highest amyloid-load in the brain, but a lower quality of
life with respect to autonomy as well as higher neuroticism. Higher self-reported physical activity in the
last twelve months went with a lower amyloid load. Higher self-reported leisure-time/ not work-related
activity went with better executive functioning at older age. CONCLUSION Even in exceptional aging,
high amyloid load may subtly influence personality and quality of life. Our findings support a close
relationship between high physical activity and low amyloid-deposition and underscore the importance
of extracurricular activities for executive functions. As executive functions are known to be a central
resource for everyday functioning in fostering extracurricular activities may be effective in delaying the
onset of dementia.
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Exceptional agers (85+ years) are characterized by preserved cognition presumably due to
high cognitive reserve. In the current study, we examined whether personality, risk and pro-
tective factors for dementia as well as quality of life are associated with core features of Alz-
heimer’s disease (amyloid-deposition and hippocampal volume) as well as cognition in
exceptional aging.
Methods
We studied 49 exceptional agers (average 87.8 years, range 84–94 years), with preserved
activities of daily living and absence of dementia. All participants received a detailed clinical
and neuropsychological examination. We used established questionnaires to measure life-
time experience, personality, recent physical and cognitive activity as well as quality of life.
Cerebral amyloid-deposition was estimated by 18-[F]-Flutemetamol-PET and manual hip-
pocampal volumetry was performed on 3D T1 MRI images.
Results
In this sample of exceptional agers with preserved activities of daily living, we found intact
cognitive performance in the subjects with the highest amyloid-load in the brain, but a lower
quality of life with respect to autonomy as well as higher neuroticism. Higher self-reported
physical activity in the last twelve months went with a lower amyloid load. Higher self-
reported leisure-time/ not work-related activity went with better executive functioning at
older age.
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Conclusion
Even in exceptional aging, high amyloid load may subtly influence personality and quality of
life. Our findings support a close relationship between high physical activity and low amy-
loid-deposition and underscore the importance of extracurricular activities for executive
functions. As executive functions are known to be a central resource for everyday function-
ing in fostering extracurricular activities may be effective in delaying the onset of dementia.
Introduction
According to the WHO, life expectancy at birth in Europe increased from 72.0 years in 2000 to
77.5 years in 2016, with a healthy life expectancy at birth of 68.4 years. As age is the most
important risk factor for dementia, this was paralleled by a rising number of patients with
dementia worldwide (50 million of people with dementia in 2019 [1]). Interestingly, recent
epidemiological studies showed that age-specific incidence of dementia decreased by 24%
from 1990 to 2000 in high-income countries supposedly due to beneficial changes in modifi-
able risk factors like higher education and reduction of vascular risk factors [2, 3].
Pathologies accumulating with higher age are beta-amyloid deposits and neurofibrillary
tangles containing misfolded Tau protein, the typical hallmarks of Alzheimer’s disease. Also
cerebrovascular brain lesions t and other additional protein aggregates like TDP43 or alpha-
synuclein become increasingly prevalent with age, and could exert a synergistic detrimental
impact on the brain [4–7]. Recent developments in brain imaging brought the possibility to
visualize certain pathologies. By using positron emission tomography with dedicated radio-
pharmaceuticals we can measure amyloid- and tau accumulation in the brain [8–13]. Amy-
loid-pathology accumulates in the brain over decades before first cognitive symptoms of
Alzheimer’s disease occur [8, 14]. Over time the decrease in brain tissue especially in medio-
temporal regions can be measured as a consequence of disease progression already in a pre-
clinical/presymptomatic stage [15–19]. However, atrophy in the mediotemporal region is not
specific to Alzheimer’s disease but occurs in various other neurodegenerative diseases, and up
to a certain degree also in normal aging [15, 20, 21]. Volume losses may be associated with cog-
nitive impairment [15, 20–22]. In a population older than 85 years the limbic predominant
age-related TDP-43 encephalopathy (LATE) is frequently detectable, but due to lacking in vivo
diagnostics for humans it can only be diagnosed post mortem [7].
Populations of exceptional agers offer a unique possibility to identify factors that moderate
the link between pathology and cognition [23–27]. Here the concept of cognitive reserve is of
high relevance. Cognitive reserve is regarded as the collection of factors that counteract the
impact of accumulation of cerebral pathologies and preserve a subject’s cognitive functions
[28–31]. To investigate the moderating influence of cognitive reserve, we examined a popula-
tion of subjects of 85 years and older without evidence for dementia and intact activities of
daily living. The central research question was whether established risk- and protective factors
for clinical dementia are also associated with biomarkers of Alzheimer’s disease pathology and
cognitive functioning in a sample of exceptional agers. Previous studies have shown relation-
ships between dementia incidence and protective factors like cognitive and physical activities
[32–36], lifetime experience [20, 37–40], or personality traits [41–44] but findings were equiv-
ocal. Higher physical activity was associated with lower brain amyloid uptake in Apolipopro-
tein E (ApoE) ε4 carriers and in participants with better cognitive performance [45–47], but
other studies did not find this relationship (for example, ref [48]). In this study, cognitive
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functions of older adults (70–89 years old) did not benefit from a two years physical activity
program [48]. Another trial showed, that aerobic exercise training increased hippocampal vol-
ume compared to a measurable decline in the control group [49].
Positive effects of lifetime experiences (e.g. education, occupational complexity, extracurric-
ular / leisure time activities) have been postulated due to observations, that these factors are
related to less hippocampal atrophy [20, 39], higher cognitive reserve in late-life [50] as well as
fewer white matter lesions and less amyloid- deposition [51]. Education seems to moderate
associations between pathologies and cognition [52] but may not directly contribute to pathol-
ogy [53]. Cardiovascular risk factors like physical inactivity, unhealthy diets, smoking, obesity
and hypertension are modifiable and thus may serve as targets for dementia prevention strate-
gies [54–56]. The impact of these factors on dementia, diabetes and cardiovascular events
depend on genetic and other external factors [57–59]. It was repeatedly demonstrated that
multifactorial interventions to modify risk factors are useful to prevent neurodegeneration and
dementia [60–63].
The concept of exceptional aging provides a framework to understand compensation or
protective mechanisms in healthy aging despite the accumulation of various pathologies, while
the study of younger currently non-demented cohorts will necessarily include subjects towards
pathways of non-successful and successful aging [64–66].
We believe that a thorough investigation of such a population could provide important
insights for disease prevention strategies. To add to this picture the design of our study, aims
to address important risk factors and their relationship to amyloid deposition and hippocam-
pal volume as biomarkers of brain pathology, and cognition. Risk factors of interest in our
study are life experiences, cognitive and physical activity. These were complemented with mea-
sures for quality of life and subjective memory complaints as possible subtle consequences of
Alzheimer’s pathology as these factors were associated with Alzheimer pathology biomarkers
in younger cognitively healthy populations [67–70]. Furthermore we studied personality traits
as they could either be a risk factor for Alzheimer’s dementia or directly influenced by Alzhei-
mer’s pathology [41–43, 71].
Materials andmethods
49 older adults (mean age 87.8 year (SD 3.0y)), recruited via advertisement or direct mailing,
participated in this study. Parts of this data set have been published previously, comparing a
part of the present sample with younger-old subjects with respect to plaque and iron load,
entorhinal cortex volume and white matter hyperintensities [72]. The oldest participant was 94
years at baseline and the youngest subject was enrolled 3.5 months before his 85th birthday.
The clinical work-up included assessment of medical history (in particular, prior episodes
of brain disease, e.g. ischemia, trauma) and familial history for neurodegenerative diseases,
psychiatric, neurological, and internal medicine status. Furthermore ECG and routine labora-
tory testing, Mini Mental Status Examination (MMSE) [73], Instrumental Activities of Daily
Living Scale (IADL) [74] and Hamilton Rating Scale for Depression [75] as well as ApoE geno-
typing were performed in all patients.
Main inclusion criteria were age of 85 or older and preserved everyday functioning. Main
exclusion criteria were clinical dementia as assessed by clinical evaluation or significant neuro-
logical, psychiatric or other diseases that may influence cognition or may interfere with the
participant’s ability to give informed consent or with compliance at the visits. The study was
conducted in accordance with the local law, the Declaration of Helsinki [76] and approved by
the ethics committee of the canton Zurich.
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Neuropsychology and domain-specific indices
Standard neuropsychological, psychiatric and neurological assessments were performed. The
rationale for test selection was to complement standard dementia tests with tests with a higher
cognitive load for each cognitive domain.
After a short informal interview to assess subjective cognitive complaints and factors with
possible influence on the test results (e.g., education, alcohol consumption and medication,
recent long-distance travel over multiple time zones) as well as characteristics of free language
expression, the following neuropsychological tests were administered in the same order: the
German version of the CERAD battery [77]; phonematic fluency over three minutes (letters)
[78]; the German version of the RAVLT (VLMT; [79]); the Rey-Osterrieth Complex Fig-
ure ([80]; including immediate and late recall, evaluated with Taylor’s criteria, [81]); Digit
span and Corsi block task (each forward and backward, as in WMS-R; [82]), nonverbal fluency
test (5-point test [83]) and Tower of London [84].
All individual test results were z-transformed based on age- and partially years of education
corrected clinical norms. The composite scores were generated by averaging all individual
transformed test scores relevant for the respective domain. The episodic memory score
included the subscores learning, recall and recognition based on VLMT task for learning and
recognition, and CERAD’s word learning, VLMT late recall and figures recall from the
CERAD battery. The working memory score consisted of Digit span and Corsi block back-
ward. The visuospatial construction score equals the Rey Figure copy, and the naming score
equals the short version of the Boston naming test. The executive score included the subscores
fluency (verbal and nonverbal fluency tests), non-fluency (colour-word interference and set
switching) and error control (based on the sum of errors in three different tests: phonematic
fluency, Stroop and Tower of London). The error control scores was a sum of the z-scores and
multiplied with (-1) to get higher values for better performances.
Questionnaire-based scales
For the lifetime experience questionnaire, the same weight scores for the sub-items were used
as in an Australian cohort (appendix C of the original publication) [85]. The questionnaire
covers three stages of aging, Young Adulthood from 13 to 30 years covering the educational
and self-identity finding and first career stage. Mid-life from 30–64 years is characterized by a
focus on work-life balance, maintenance of relationships and growing importance of caregiv-
ing for children or parents. Late life starts at age of 65 years where many people are retiring
and have to reorient their activities beyond work. The questions for each life stage comprise
two sets. The first consists of questions on education and work-related activities and the sec-
ond consisted of general questions about leisure, physical and social activities. We labeled
those as ‘extracurricular activities’, as they are not directly related to work or education. Sam-
ple questions for these activities are how often participants played or practiced a musical
instrument, did artistic pastime, sports or other physical activities, how often they met with
friends or family, how often they read, whether they spoke a second language or how far they
have travelled across continents.
The WHOQOL-OLD questionnaire in its original German version by the WHO was used
to assess quality of life (QOL) in the six domains: sensory abilities, autonomy, past, present
and future activities, social participation, death and dying as well as intimacy [86]. The ques-
tionnaire consists of 24 questions answered on a 5-point scale. The questions assess QOL over
the last two weeks. Sample Questions for the six domains are: “To what extent do impairments
to your senses (e.g., hearing, vision, taste, smell, touch) affect your daily life?”, “How much
freedom do you have to make your own decisions?” “How much do you feel that you have
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received the recognition you deserve in life?”, “How satisfied are you with the way you use
your time?”, “How scared are you of dying?”, “To what extent do you experience love in your
life?”.
To assess current cognitive and physical activities over the last 12 months, a standardized
questionnaire was used as described in the original publication [32]. The questionnaire
assesses ten cognitive activities like reading, playing games and music, arts and crafting activi-
ties as well as social activities were measured. Watching TV for a certain amount of hours did
not count for the final cognitive score. In addition the questionnaire covers six physical activi-
ties, namely light activities like laundry, vacuuming and light exercises like walking; moderate
activities and exercise like gardening or aerobics and strength training as well as information
on heavy activities and vigorous exercises like heavy digging, or tennis and jogging. All activi-
ties were weighted according frequency of performance of once a month or less (0 points), 2–3
times per month (0.5), 1–2 times per week (1.5), 3–4 times per week (3.5), 5–6 times per week
(5.5) and 7 points for daily activities. For cognitive activities a maximum of 70 and for physical
activities a maximum of 42 could be reached.
The NEO-FFI was applied to assess the five personality domains, with a particular interest
neuroticism as its probable relationship with healthy aging and Alzheimer‘s-related pathology
[87].
Subjective cognitive complaints were assessed according to Schmand et al.,1996 [70]. This
questionnaire consists of 10 items on memory complaints. Example questions are whether
other people found the participants forgetful and how often they forgot things, became con-
fused or had concentration problems.
Imaging based Alzheimer’s diseases biomarkers
All participants received a standard dynamic PET/MR (Signa PET/MR GE Healthcare) scan
with approx. 140MBq of 18[F]-Flutemetamol. A BRAVO 3D T1MRI sequence with voxel size
1mm (8-channel coil) was acquired in parallel to calculate cortical beta-amyloid SUVR with
bilateral cerebellar grey matter reference for the PET data analysis, which was conducted with
the PMODNeuroTool 3.6 (PMOD Technologies LLC., Switzerland).
To minimize white matter spillover signal and to reduce partial volume effects from cere-
brospinal fluid in grey matter regions of interest in the PET data, MRI images were segmented
with 3 probability maps. Cortical regions of interest were defined according to Hammer’s
maximum probability atlas. Deep nuclei parcellation was performed with NeuroTool (knowl-
edge based, with 20 reference sets). The cut-off for grey matter–white matter segmentation
was selected at 50% probability. Automatic outlining of the regions of interest was evaluated
by an expert (VT) in each individual scan and corrected manually in PMOD if necessary. Late
phase uptake values were calculated as average late frames activity (85 to 100 minutes post
injection). The region of interest estimating cortical amyloid-load was defined as the average
of cortical Hammer’s atlas defined regions that are overlapping with centiloid regions defini-
tion [88] thus not including regions in mediotemporal, occipital, central structures as well as
pre- and postcentral gyrus.
A higher-resolution 3D T1 FSPGR (IR600, voxel size 0.5mm) image scanned on a 750W 3T
(32-channel coil)-scanner was used for manual outlining of hippocampal volume by an expert
(AB).
Volumes were outlined using MRICroN on the coronal slices of the 3D images (with the
axial and sagittal views open to verify). The most posterior slice of the anterior hippocampus
was outlined as the last (most posterior) slice where the upper part (‘cover’) of the hippocam-
pus goes as far medial as the lower part in an unbroken sheet of grey matter (before the ‘snail’-
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shape starts; within-structure landmark). Each hippocampus was outlined in an anterior-to-
posterior fashion. Fimbria and fornix were excluded. Dark holes were cut out if they were
wider than the size of the pen. Volumes in cm3 were divided by whole brain volume as derived
from SPM 8 VBM (fil.ion.ucl.ac.uk/spm) and results were multiplied by 10’000 for readability.
Total hippocampal volume was calculated as averaged sum of the left and right anterior plus
posterior hippocampal volumes.
Statistics
Statistical analysis was done with SPSS 25 (IBM). As this is an exploratory study, all p-values
are reported uncorrected. The number of analyses done for each research question is provided
in the result sections. SUVR values were used in the analyses as continuous variable or as quar-
tile groups. Median cortical SUVR values were 1.41 (IQR 0.3) (mean 1.56, SD 0.48) and ranges
based on quartiles were as follows: Q1 = 1.09–1.29, Q2 = 1.29–1.40, Q3 = 1.40–1.60,
Q4 = 1.60–3.2.
Nonparametric testing was performed wherever assumptions for parametric testing (Gauss-
ian distribution as assessed by Kolmogorov-Smirnov test) were not met, which was the case in
the majority of variables. In supplemental S1 Table we listed all continuous variables with the
results of the Kolmogorov-Smirnov test. To include potential confounders we used partial
regression or general linear modelling to explore the effects of potential confounders. The con-
tinuous variables were transformed by replacing outliers with cutoff values (standard deviation
>3) and rescaled them with a Box-Cox transformation to mean 0 and standard deviation 1 as
implemented in SPSS.
Spearman’s tests were used for the primary correlational analyses without adjustment for
age, sex and education. Significant correlations were additionally tested with partial correla-
tions with the respective covariates age, sex and education using the Box-Cox transformed
continuous variables.
In a similar vein, group comparisons were calculated with Kruskal-Wallis tests (3 or more
categories) or Mann-Whitney U tests (2 categories); significant comparisons were explored
further with the respective general linear modelling methods including the covariates age, sex
and education using the Box-Cox transformed variables.
ApoE 4 Genotype was not included in the analyses due to the low number of ε4 carriers (6)
half of which had the combination ε2/ε4.
All tests were performed two-sided.
Power analysis for correlations was calculated using the final sample size N = 49 and type I
error of 0.05. With the program G�power the post-hoc power calculation for correlation analy-
sis was used testing against an H0 hypothesis of a rho = 0 [89].
Results
Description of study population
Table 1 summarizes demographic and clinical parameters of the study population. The IADL
includes the actual points of subject scores irrespective whether a task was never performed in
lifetime or could not be performed due to other reasons, e.g., physical incapacity. Fig 1 shows a
horizontal section of an 18[-F]-Flutemetamol scan indicative of high amyloid load (A) and
with low amyloid load (B) as well as the distribution of cortical SUVR values in the study
population.
Whole brain volume corrected hippocampal volumes (left plus right side) were on average
9.5 (SD 1.46) with a range of 7.6 to 15.33.
No correlations were detectable between cerebral amyloid-load and hippocampal volume.
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Sex and age effects
Women and men did not differ in age, whole brain volume corrected hippocampal volume
and amyloid-load. Compared to men, women had fewer years of education (Mann-Whitney
U = 370.5, p = 0.011) and less total lifetime experience in midlife (Mann-Whitney U = 367.5,
p = 0.014), especially in job-related categories (Mann-Whitney U = 464, p = 0.001). No differ-
ences were seen in the neuropsychological composite score except for episodic memory recall
score where women scored better (Mann-Whitney U = 139, p = 0.032).
Neither cerebral amyloid-load nor hippocampal volume correlated with age. In addition,
no neuropsychological performance variable correlated with age (note that z-values were par-
tially age-corrected and age range was limited in this study).
Table 1. Overview on study sample.
Mean (SD) or number (%)
Age 87.8 years (2.99)
sex (female/male) 15 / 34 (30.6% / 69.4%)
Education 14.12 years (2.9)
Education by sex (female/male) 12.87 (2.2) / 14.68 (3.0)
BMI 25.6 (3.2)
Hamilton score 1.35 (2.1)
MMSE 28.35 (1.8)
IADL items 7.33 (1.6)
living on their own alone 26 (53.1%)
living at home with partner 20 (40.8%)
living in dedicated home for older adults 3 (6.1%)
nursing support at home 3 (6.1%)
domestic help/ cleaner used 30 (61.2%)
active driving 29 (59.2%)




Risk factors and cardiovascular disease
self-reported cognitive reduction noted (only 3 confirmed by relatives) 23 (46.9%)
sleeping problems 13 (26.5%)
current smokers (2 only pipes) 3 (6.1%)
never smoked 22 (44.9%)
smoked in the past 24 (49%)
alcohol<80ml 43 (87.8%)
alcohol>80ml 1 (2%)
no alcohol 5 (10.2%)
arterial hypertension 39 (79.6%)
Diabetes 4 (8.2%)
Hypercholesterinaemia 20 (40.8%)
history of myocardial infarction 9 (18.4%)
first grade relatives with dementia 5 (10.2%)
Data is presented as mean and standard deviation or number of cases and percentages of the total study population.
https://doi.org/10.1371/journal.pone.0247225.t001
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Cognitive performance–no association with imaging biomarkers
MMSE score did not correlate with corrected hippocampal volume nor with amyloid-load.
Neuropsychological test performance did not correlate with amyloid-load in any of the cogni-
tive domains.
One significant and negative correlation between cognitive composite scores and hippo-
campal volume was identified with the recognition score (Spearman’s rho = -0.297, p = 0.042).
The partial correlation using transformed variables and with covariates age, sex and education
the correlation remained was significant (r = -0.317, p = 0.036, df = 42).
Table 2 lists the values of the composite scores overall and for the groups representing first
and fourth quartile of amyloid deposition. None of the differences were significant (Mann-
Whitney U: p> 0.25). As some participants did not perform all tasks the number of datasets is
indicated next to the composite scores in brackets.
We used the subjective memory questionnaire [70] to assess memory complaints in a stan-
dardized manner. 19 (38.8%) participants stated no memory complaints, 29 (59%) stated com-
plaints without resulting daily life problems. Only one subject stated memory complaints with
resulting problems. The overall test score was low (total score of 2.1; SD 1.5). There was no
Fig 1. Example Images and distribution of amyloid SUVR. A: Example of a participant with amyloid SUVR = 3.2, age = 86,
MMSE = 29 and ApoE = ε3/ε3. The 4mmGaussian filtered image displays SUVR is scaled from 0–4.5 SUVR. B: example of a
participant with amyloid SUVR = 1.2, age = 86, MMSE = 29 and ApoE = ε3/ε3. The SUVR image is scaled from 0–3.5 SUVR. C:
histogram of cortical amyloid SUVR (reference region was bilateral cerebellar grey matter).
https://doi.org/10.1371/journal.pone.0247225.g001
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correlation of the total score with amyloid-load (SUVR), hippocampal volumes or cognitive
tests (12 correlations were performed).
Highest amyloid load is associated with lower experience of autonomy
Our participants had a total quality of life score of 93.9 (ranging from 63–115, SD 11.3) consid-
ering the possible scoring range of 24–120 of the WHOQOL-OLD [86].
The average and standard deviation values of the sub scores are listed in Table 3.
With respect to the relationship with amyloid the QOL aspect autonomy showed a signifi-
cant difference between the 4 quartiles of amyloid-load (Kruskal-Wallis 7.9, p = 0.047). Visu-
ally the highest amyloid SUVR subgroup showed lower values than the other groups. But the
post hoc Mann-Whitney U comparison between Q4 and Q1-3 did not show significance
(U = 145.5, p = 0.072). A total of 7 comparisons were made.
In Table 3 the QOL values for the first and fourth quartile are displayed. Over all facets, the
average value of the participants in the group with highest amyloid load was lower than the val-
ues from the group with lowest amyloid load. None of the direct comparisons between sub-
groups quartile 1 versus quartile 4 reached significance (Mann-Whitney-U p>0.16).
Table 2. Neuropsychological assessment results.
Composite Scores for Domains (N completed) All subjects mean (SD) Q1 Amyloid load Q4 Amyloid load ε2/ε3 or ε3/ε3 ε2/ε4 or ε3/ε4
Working Memory score (48) -0.30 (0.9) -0.11 (0.9) -0.43 (1.0) -0.35 (0.8) 0.11 (1.1)
Learning score (47) -0.05 (0.8) -0.02 (0.7) -0.15 (1.0) -0.10 (0.8) 0.33 (0.8)
Recall score (47) -0.18 (0.9) -0.13 (0.8) -0.07 (1.0) -0.30 (0.9) 0.61 (0.7)
Recognition score (47) -0.47 (1.2) -0.64 (1.1) -0.52 (1.4) -0.53 (1.2) -0.07 (1.1)
Executive Functions score (44) 0.07 (0.5) 0.03 (0.4) -0.06 (0.5) 0.04 (0.5) 0.30 (0.4)
Fluencies subscore (46) -0.01 (0.7) -0.08 (0.7) -0.19 (0.6) -0.02 (0.7) 0.08 (0.6)
Not Fluencies subscore (46) 0.21 (0.6) 0.30 (0.4) 0.14 (0.5) 0.19 (0.6) 0.39 (0.3)
Error Control subscore (45) -1.02 (1.0) -0.80 (0.8) -1.50 (1.4) -1.07 (1.0) -0.67 (0.5)
Visuo Construction score (47) -0.14 (0.9) -0.11 (1.3) 0.01 (0.8) -0.07 (0.8) -0.69 (1.7)
Naming score (48) 0.60 (1.1) 0.66 (1.1) 0.52 (1.4) 0.50 (1.1) 1.30 (0.8)
Z-scores of the composites derived from the neuropsychological examination. Executive functions score is split in three sub scores. The first column lists total average
scores with standard deviation in parentheses, the next two columns list the scores of the participants with lowest and highest amyloid load (quartile 1 and quartile 4 of
cortical amyloid SUVR). No differences in cognitive functions were observed with respect to amyloid load (p>0.25 Mann-Whitney U Test). Also ε4 carrier and non-
carriers were grouped in the last two columns. The respective neuropsychological Z-score values are presented. As there were only 6 ε4 carriers the averages need to be
interpreted with care and no statistical comparisons were performed due to this imbalance. Z-scores in bold indicate values higher/better than total average of the
sample.
https://doi.org/10.1371/journal.pone.0247225.t002
Table 3. Results of WHOQOL-OLD split by amyloid load and with reference values.
WHOQOL-OLD Facets Study Sample Q1 Amyloid load Q4 Amyloid load
mean (SD) mean (SD) mean (SD)
Sensory Abilities 15.00 (3.27) 16.42 (2.71) 13.83 (4.04)
Autonomy 16.49 (2.39) 16.42 (2.50) 15.25 (2.99)
Past, Present and Future activities 16.02 (2.11) 16.25 (2.22) 15.67 (2.06)
Social Participation 15.39 (2.58) 14.67 (2.31) 14.92 (3.09)
Death and Dying 15.35 (3.69) 16.17 (3.41) 15.17 (3.86)
Intimacy 15.69 (3.30) 15.42 (4.12) 13.92 (3.45)
Total 93.94 (11.31) 95.33 (9.91) 88.75 (14.05)
Results of the WHOQOL-OLD questionnaire. Values of the subgroups with lowest and highest amyloid load (Amyloid quartile 1 and 4) are displayed.
https://doi.org/10.1371/journal.pone.0247225.t003
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To test for a potential influence of covariates (age, sex and education) a parametric univari-
ate statistics (general linear model) was computed with Box-Cox transformed variables. The
corrected model (F(6,48) = 2.43, p = 0.042, partial eta squared = 0.257). The effects of the covari-
ates were not significant (all p>0.05 and partial eta squared<0.09) but the effect of the fixed
factor amyloid-load (amyloid quartiles) was significant (F(3,48) = 3.879, p = 0.016, partial eta
squared = 0.217) showing an effect on the dependent variable autonomy.
Association of amyloid with neuroticism and extraversion scores
The scores measured with the German version of the NeoFFI [87] were 15.3 (SD 6.6) for neu-
roticism, 25 (SD 5.9) for extraversion, 28 (SD 6.8) for openness for experience, 34.7 (SD 5.8)
for agreeableness and 35.2 (SD 6) for conscientiousness.
Scores for neuroticism (Kruskal-Wallis 9.18, p = 0.027) and extraversion (Kruskal-Wallis
15.22, p = 0.002) were significantly different among the quartiles of amyloid-distribution.
Visually the quartile with the highest amyloid-load showed reduced extraversion and increased
neuroticism compared to Q1-3. Mann-Whitney U post hoc test between Q4 and Q1-3 showed
for both significant results (neuroticism Mann-Whitney U = 319.5, p = 0.023; extraversion
U = 106, p = 0.007).
To test for the influence of age, sex and education a multivariate analysis for repeated mea-
sures (NeoFFI as repeated measure with neuroticism and extraversion) with these covariates
and factor amyloid load was performed with Box-Cox transformed variables. No significance
for the repeated factor NeoFFI or the covariates (p>0.6) except for factor amyloid quartiles (F
(3,42) = 6.515, p = 0.001, partial eta squared 0.318) (significance remained unaffected by a
Greenhouse-Geisser correction as compared to the assumption of sphericity). Fig 2 depicts the
marginal means of the two NeoFFI scores against SUVR Quartiles. The comparison between
Q1-3 and Q4 amyloid load groups revealed similar results which only amyloid as significant
effect with NEOFFI (F(3,44) = 10.33, p = 0.002, partial eta squared 0.190).
Also for between-subjects effects for both personality traits univariate tested the factor amy-
loid quartiles was significant (neuroticism: F(3,48) = 3.498, p = 0.024, partial eta squared =
0.200; extraversion: F(3,48) = 5.623, p = 0.002, partial eta squared = 0.287). None of the covari-
ates were significant. The corrected model showed a significant effect for extraversion (F(6,48)
Fig 2. Plot of estimated marginal means of extraversion and neuroticism score against amyloid load. Plot of the
estimated marginal means of the two NeoFFI measures as estimated in the repeated measures model with the
covariates age, sex and education. Neuroticism against amyloid quartiles is plotted in blue and extraversion in red.
Variables were Box-Cox transformed.
https://doi.org/10.1371/journal.pone.0247225.g002
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= 2.940, p = 0.017, partial eta squared 0.296) and showed no significance for neuroticism (F
(6,48) = 2.005, p = 0.086, partial eta squared = 0.223).
Participants with lower amyloid-load (Q1-Q3 only) showed a visual but not significant
trend of reduced neuroticism scores with higher amyloid-load (rho = -0.233, p = 0.164) and a
significant positive correlation with extraversion (rho = 0.402, p = 0.014). SUVR values rang-
ing from Q1-Q3 are normal distributed (Kolmogorov-Smirnov Z = 0.082, p = 0.2).
When performing a partial correlation with control variables age, sex and education and
SUVR with all NEOFFI scores extraversion was significantly correlating with SUVR (r = 0.39,
p = 0.023, df = 32) while neuroticism was not (r = -0.236, p = 0.178, df = 32). For this test, all
variables were transformed within the reduced sample.
Total brain volume-corrected hippocampal volume showed a significant correlation with
agreeableness (rho = -0.308, p = 0.031) but none for the other traits. Five comparisons
were made for each research question. Performing a partial correlation with age, sex and edu-
cation as covariates no correlation was significant (p>0.080, with Box-Cox transformed
variables).
Potential protective factors—current physical and cognitive activities
The scores for cognitive activity were ranging from 5–37 and for physical score from 2–35.
Values of the score also for subgroups for amyloid load, ApoE genotype and sex are listed in
Table 4.
Physical but not cognitive activity over the last 12 months correlated negatively with cortical
amyloid deposition (rho = -0.307, p = 0.032) see also Fig 3. Neither score correlated with cor-
rected hippocampal volume.
Performing a partial regression with age, sex and education as covariates the correlation did
remain significant (r = -0.303, p = 0.041, df = 44, performed with transformed variables). Nei-
ther age, sex nor education did correlate with a Spearman’s correlation with physical activity
score (p>0.27).
Table 4. Results of the cognitive and physical activity questionnaire.
cognitive activities physical activities
Amyloid Quartiles (N)
1 (12) Mean 20.6 (7.2) 11.9 (4.2)
2 (12) Mean 20.5 (7.9) 10.5 (5.5)
3 (13) Mean 20.7 (7.5) 10.5 (8.3)
4 (12) Mean 21.3 (5.4) 9.3 (5.1)
ApoE Genotype (N)
E2/E3 (9) Mean 23.3 (6.5) 15.9 (8.5)
E2/E4 (3) Mean 26.0 (5.5) 12.8 (4.3)
E3/E3 (34) Mean 20.0 (6.9) 9.0 (4.7)
E3/E4 (3) Mean 17.3 (6.8) 9.7 (1.3)
sex (N)
female (15) Mean 23.3 (8.0) 11.8 (8.2)
male (34) Mean 19.7 (6.1) 10.0 (4.7)
Total (49) Mean 20.8 (6.9) 10.6 (5.9)
Table 4: Results of the activity questionnaire with respect to Amyloid load, APOE or sex group. Mean values with
standard deviation in parentheses are listed.
https://doi.org/10.1371/journal.pone.0247225.t004
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Effects of lifetime experiences
Educational, work-related and extracurricular activities measured with the lifetime experience
questionnaire’s (LEQ) [85] were neither associated with cortical amyloid-load nor with hippo-
campal volume. On average, our sample had a total LEQ of 89.12 (SD 13.1, range 60–120).
Importantly, total lifetime experience correlated with the executive function score
(p = 0.014, rho = 0.367) but not with the other assessed cognitive domains. Detailed analysis of
the three executive-function subscores revealed that the error control score correlated most
strongly with extracurricular and total lifetime experience in all three age stages. The strongest
associations were observed for the non-specific subscores (extracurricular activities) but nei-
ther for work nor education-related experiences. The partial correlation with covariates age,
sex and education showed similar results.
Fig 4 one correlation between midlife extracurricular experiences and executive cognitive
function score is visualized. The correlation matrix between the LEQ items and the executive
function scores is visualized in Fig 5 including indications of significance levels for Spearman’s
correlation and partial correlation with covariates.
Discussion
Our selected sample of participants has aged beyond the age of 85 without dementia and with
preserved activities of daily living. We have seen that biological markers of Alzheimer’s disease
(amyloid and hippocampal volume) and cognitive performance were not related to each other
in a way that would reflect the AD typical biomarker scheme where high amyloid and reduced
hippocampal volume are related to lower cognitive performance [15, 90].
High amyloid load- may be associated with lower quality of life and a
change in personality
Despite the absence of significant cognitive-amyloid or cognitive-hippocampal volume corre-
lations, we found early signs of amyloid-related effects outside the cognitive domain. We
showed the impact of high amyloid load on quality of life with respect to the experience of
autonomy and on personality scores.
Fig 3. Correlation physical activity score against amyloid SUVR. Scatter plot between physical activity score and
amyloid SUVR. The correlation is significant (rho = -0.307, p = 0.032) and indicates that participants with higher
physical activity have lower amyloid SUVR.
https://doi.org/10.1371/journal.pone.0247225.g003
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With respect to a putative impact of personality, our findings indicate that personality traits
like extraversion and neuroticism are related to amyloid-load. However, we are examining a
sample with relatively low scores for neuroticism and a high quality of life. Our study popula-
tion showed personality scores comparable to the general population [91], and a 65+ years
population in Switzerland [92], with slightly lower neuroticism in our sample. Participants in
the highest amyloid-load quartile displayed higher scores for neuroticism and lower scores for
extraversion than the three lower amyloid quartiles. This effect was not monotonous along the
entire range of amyloid-load.
Increased neuroticism seems to be a preceding signal for dementia [43, 93] as well as for
mild cognitive impairment [94, 95]. A study with healthy volunteers (average age 81 years)
showed a link between high neuroticism and beta-amyloid deposition in subjects with subjec-
tive cognitive complaints [96]. In our smaller and older sample, we did not see the same inter-
action but subjective memory complaints went with higher neuroticism scores. Various
studies have shown changes in personality preceding dementia diagnosis [41, 42, 71, 97, 98].
We therefore suspect a subtle personality change in the high-amyloid subjects rather than a
direct biological link as a mechanism to explain the relation.
In addition, we found that subjects with higher amyloid-load had a reduced autonomy
score in the quality of life questionnaire. This is consistent with our findings on higher neurot-
icism and an additional indication that even in subjects with high cognitive reserve, amyloid
pathology may become reflected in other, non-cognitive aspects.
The influence of physical and cognitive activities
We found an association of current physical activity with amyloid deposition, but neither with
hippocampal volume nor cognitive measures, in our exceptional agers. The literature on a
direct effect of physical activity on amyloid deposition in humans is less compelling than in
animal models [99]. Nevertheless, several cross-sectional studies have already shown lower
brain amyloidosis in participants with higher physical activity [45–47]. A recent longitudinal
Fig 4. Correlation between midlife extracurricular experiences and executive cognitive functions. Significant
correlation between executive function scores and midlife extracurricular experiences (measured with LEQ).
Spearman’s rho = 0.513, p<0.001 or Pearson’s partial correlation (with covariates age, sex and education and Box-Cox
corrected variables) r = 0.499, p = 0.001. Color indicates amyloid load quartiles (Quartile 1 lowest and Quartile 4
highest amyloid SUVR).
https://doi.org/10.1371/journal.pone.0247225.g004
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study in healthy participants (average 73.4 years) found that more physical activity was associ-
ated to slower amyloid related cognitive decline and gray matter volume loss [100]. As we have
no longitudinal data on physical activity, we cannot exclude that reduced physical activity
could also be a consequence of increased amyloid-deposition that would be consistent with
our findings on autonomy and personality.
Lifetime experience contributes to excecutive functioning
One of the most important protective factors for good cognitive functions at high age is cogni-
tive reserve [30, 90, 101–103]. Our sample displayed a lower amount of cognitive complaints
than others [104] which may reflect that our sample consisted of selected cognitively healthy
individuals with a high cognitive reserve. Even in our sample, we found lifetime experience
and especially extracurricular activities to go alongside with better executive functions in older
age. Our results therefore underscore the direct relevance of lifetime experience for executive
functioning. This effect did not seem to be mediated by pathology, as increased experience was
not correlated with amyloid deposition or hippocampal volume.
In a younger cohort (66–88 years old) a similar relationship between lifestyle and cognition
has been shown with a general measure of cognitive ability but without including information
about AD biomarkers [50]. A recent study in 330 younger participants without dementia
found no effect of midlife cognitive activities on late life amyloid accumulation (i.e., altering
pathogenesis) but an effect on late life cognitive performance [105]. Concerning lifetime
Fig 5. Correlation matrix between lifetime-experiences and executive cognitive functions. Correlation matrix between executive
functions scores and Lifetime experience questionnaire scores. Color and numbers indicate the Spearman’s rho value. Color white
indicates non-significance (p>0.05). Stars indicating significance level in the Spearman’s correlation and circles significance in the
partial correlation with corrected variables (� or ˚ indicates significance on p = 0.05 level and �� or ˚˚ indicates significance on p = 0.01
level).
https://doi.org/10.1371/journal.pone.0247225.g005
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experience and hippocampal volume a systematic meta-analysis identified an association [106]
even though not all studies showed this relationship [32]. However, in a slightly younger popu-
lation (average 80.8 years) of cognitively intact subjects, a positive correlation between lifetime
experience and hippocampal volume was seen, especially with midlife experience score [39].
Especially participants with higher self-paced motivated extracurricular activities profit
from better executive functions scores at later life [101, 102, 107–109]. Executive functioning is
crucial for mastering everyday life: A recent study demonstrated in 452 MCI patients that exec-
utive function is crucial for progression of MCI to dementia [110]. Thus, strengthening life-
time experience and especially extracurricular activities may serve as a central strategy to
prevent or increase time to conversion in dementia of all kind, irrespective of pathology.
Hippocampal volume shows no typical association with memory
performance
The negative correlations between hippocampal volume and neuropsychological test perfor-
mance in our sample were rather unexpected in older adult cohorts (though not unique, see
[111]), but have been repeatedly described in younger subjects [112, 113]. In the current cross-
sectional analysis, we cannot test if hippocampal atrophy is a risk for further cognitive decline.
A recent longitudinal study where non-demented 82+ year old participants were followed up
for 7–15 years showed a significant association with memory decline and isolated hippocampal
atrophy (in absence of amyloid positive deposition) [114]. In the same study, isolated amyloid
positivity (preserved hippocampal volume) was associated with memory and executive decline,
while at baseline the effect of amyloid deposition was not significant.
Methodological considerations
Our sample included only 30.6% women. This is less than in other cohorts and does not reflect
the sex proportion in this age group in the general population [115, 116]. Distribution of ApoE
genotypes in our sample was similar to other studies in exceptional aging showing low fre-
quencies of the epsilon 4 allele and high frequencies of the epsilon 2 allele. [115–117].
With our sample size and statistical methods, we were only able to detect moderate to
strong associations so we cannot rule out subtler effects on AD-biomarkers that would have
been uncovered with larger sample sizes, but could still play an important role on an epidemio-
logical level.
We had a power of 83% to detect correlations with effect size of rho = 0.4. For weaker corre-
lations (i.e., rho = 0.3) we only had a power of 56% in our sample.
As this is an exploratory study we chose not to correct our p-values for multiple testing as
discussed in detail by others [118]. For all studied comparisons and associations, a scientific
rationale existed a priori. In order to capture the specifics of this sample under study we pres-
ent the different aspects of the study within one publication. We believe that this provides the
reader with a more comprehensive picture of the data even if this leads to more comparisons
within one publication.
We used state of the art and highly standardized imaging as well as clinical assessment
methods to characterize biomarkers, health status and lifestyle factors in this sample. We care-
fully executed dedicated imaging analysis, taking care of the advanced age of this group and
ensuring reliable values.
Conclusion
We have seen that features of Alzheimer’s pathology occur frequently at higher age in healthy
subjects in the absence of dementia. However, the typical association of amyloid with
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hippocampal volume loss and impaired memory function, which characterizes the pathway to
Alzheimer’s disease, is not present in these exceptional agers.
Importantly, our results indicate that even in exceptional aging, high amyloid load may
have already subtle effects on personality and quality of life irrespective of effects on cognition.
We support the notion of a protective effect of physical activity on amyloid-deposition. In
addition, extracurricular lifetime experience plays an important role for later executive cogni-
tive functions irrespective of Alzheimer’s pathology and thus enhancing such experience may
serve as a general protective strategy for dementia.
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Gedächtnis Test- Revidierte Fassung (WMS-R). Bern: Hans Huber; 2000.
83. Regard M, Strauss E., Knapp P. Children’s production on verbal and nonverbal fluency tasks. Percep-
tual and Motor Skills. 1982; 55(3 Pt 1):839–44.
84. Shallice T. Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci. 1982; 298
(1089):199–209. Epub 1982/06/25. https://doi.org/10.1098/rstb.1982.0082 PMID: 6125971.
85. Valenzuela MJ, Sachdev P. Assessment of complex mental activity across the lifespan: development
of the Lifetime of Experiences Questionnaire (LEQ). Psychol Med. 2007; 37(7):1015–25. Epub 2006/
11/23. https://doi.org/10.1017/S003329170600938X PMID: 17112402.
86. Winkler I, Matschinger H, Angermeyer MC. [TheWHOQOL-OLD]. Psychotherapie, Psychosomatik,
medizinische Psychologie. 2006; 56(2):63–9. Epub 2006/02/03. https://doi.org/10.1055/s-2005-
915334 PMID: 16453244.
87. Gerhard U. Borkenau P. & Ostendorf F. (1993). NEO-Fünf-Faktoren Inventar (NEO-FFI) nach Costa
und McCrae. Göttingen: Hogrefe. Preis DM 84. 1999; 28(2):145–6. https://doi.org/10.1026//0084-
5345.28.2.145
88. KlunkWE, Koeppe RA, Price JC, Benzinger TL, Devous MD Sr., Jagust WJ, et al. The Centiloid Proj-
ect: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015; 11(1):1–
PLOS ONE Lifetime experience and physical activity in exceptional aging
PLOSONE | https://doi.org/10.1371/journal.pone.0247225 February 19, 2021 21 / 23
15 e1–4. https://doi.org/10.1016/j.jalz.2014.07.003 PMID: 25443857; PubMed Central PMCID:
PMC4300247.
89. Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for cor-
relation and regression analyses. Behavior research methods. 2009; 41(4):1149–60. Epub 2009/11/
10. https://doi.org/10.3758/BRM.41.4.1149 PMID: 19897823.
90. Jack CR Jr. Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will
play. Radiology. 2012; 263(2):344–61. https://doi.org/10.1148/radiol.12110433 PMID: 22517954;
PubMed Central PMCID: PMC3329271.
91. Körner A, DrapeauM, Albani C, Geyer M, Schmutzer G, Brähler E. Deutsche Normierung des NEO-
Fünf-Faktoren-Inventars (NEO-FFI). [German norms for the NEO-Five Factor Inventory.]. Zeitschrift
für Medizinische Psychologie. 2008; 17(2–3):133–44.
92. Ouanes S, Castelao E, von Gunten A, Vidal PM, Preisig M, Popp J. Personality, Cortisol, and Cogni-
tion in Non-demented Elderly Subjects: Results from a Population-Based Study. Front Aging Neurosci.
2017; 9:63. Epub 2017/03/30. https://doi.org/10.3389/fnagi.2017.00063 PMID: 28352228; PubMed
Central PMCID: PMC5348534.
93. Johansson L, Guo X, Duberstein PR, Hallstrom T, Waern M, Ostling S, et al. Midlife personality and
risk of Alzheimer disease and distress: a 38-year follow-up. Neurology. 2014; 83(17):1538–44. https://
doi.org/10.1212/WNL.0000000000000907 PMID: 25274849.
94. Caselli RJ, Langlais BT, Dueck AC, Henslin BR, Johnson TA, Woodruff BK, et al. Personality Changes
During the Transition from Cognitive Health to Mild Cognitive Impairment. J AmGeriatr Soc. 2018; 66
(4):671–8. Epub 2018/01/18. https://doi.org/10.1111/jgs.15182 PMID: 29341070; PubMed Central
PMCID: PMC5906173.
95. Mendez Rubio M, Antonietti JP, Donati A, Rossier J, von Gunten A. Personality traits and behavioural
and psychological symptoms in patients with mild cognitive impairment. Dementia and geriatric cogni-
tive disorders. 2013; 35(1–2):87–97. Epub 2013/02/01. https://doi.org/10.1159/000346129 PMID:
23364170.
96. Snitz BE, Weissfeld LA, Cohen AD, Lopez OL, Nebes RD, Aizenstein HJ, et al. Subjective Cognitive
Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults. Am J Geriatr Psy-
chiatry. 2015; 23(9):985–93. Epub 2015/03/10. https://doi.org/10.1016/j.jagp.2015.01.008 PMID:
25746485; PubMed Central PMCID: PMC4532656.
97. Smith-Gamble V, Baiyewu O, Perkins AJ, Gureje O, Hall KS, Ogunniyi A, et al. Informant reports of
changes in personality predict dementia in a population-based study of elderly african americans and
yoruba. Am J Geriatr Psychiatry. 2002; 10(6):724–32. Epub 2002/11/13. PMID: 12427581.
98. Dawson DV,Welsh-Bohmer KA, Siegler IC. Premorbid personality predicts level of rated personality
change in patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 2000; 14(1):11–9. Epub
2000/03/16. https://doi.org/10.1097/00002093-200001000-00002 PMID: 10718200.
99. Brown BM, Peiffer J, Rainey-Smith SR. Exploring the relationship between physical activity, beta-amy-
loid and tau: A narrative review. Ageing Res Rev. 2019; 50:9–18. Epub 2019/01/08. https://doi.org/10.
1016/j.arr.2019.01.003 PMID: 30615936.
100. Rabin JS, Klein H, Kirn DR, Schultz AP, Yang HS, Hampton O, et al. Associations of Physical Activity
and beta-Amyloid With Longitudinal Cognition and Neurodegeneration in Clinically Normal Older
Adults. JAMANeurol. 2019. Epub 2019/07/18. https://doi.org/10.1001/jamaneurol.2019.1879 PMID:
31312836; PubMed Central PMCID: PMC6635892.
101. Roe CM, Mintun MA, D’Angelo G, Xiong C, Grant EA, Morris JC. Alzheimer disease and cognitive
reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake. Arch
Neurol. 2008; 65(11):1467–71. Epub 2008/11/13. https://doi.org/10.1001/archneur.65.11.1467 PMID:
19001165; PubMed Central PMCID: PMC2752218.
102. Arenaza-Urquijo EM, Vemuri P. Resistance vs resilience to Alzheimer disease: Clarifying terminology
for preclinical studies. Neurology. 2018; 90(15):695–703. Epub 2018/03/30. https://doi.org/10.1212/
WNL.0000000000005303 PMID: 29592885; PubMed Central PMCID: PMC5894932.
103. Soldan A, Pettigrew C, Albert M. Evaluating Cognitive Reserve Through the Prism of Preclinical Alz-
heimer Disease. The Psychiatric clinics of North America. 2018; 41(1):65–77. Epub 2018/02/08.
https://doi.org/10.1016/j.psc.2017.10.006 PMID: 29412849; PubMed Central PMCID: PMC5806143.
104. Pires C, Silva D, Maroco J, Gino S, Mendes T, Schmand BA, et al. Memory complaints associated
with seeking clinical care. Int J Alzheimers Dis. 2012; 2012:725329. Epub 2012/04/27. https://doi.org/
10.1155/2012/725329 PMID: 22536537; PubMed Central PMCID: PMC3320051.
105. Rawlings AM, Sharrett AR, Mosley TH, Wong DF, Knopman DS, Gottesman RF. Cognitive Reserve in
Midlife is not Associated with Amyloid-beta Deposition in Late-Life. J Alzheimers Dis. 2019; 68
(2):517–21. Epub 2019/02/19. https://doi.org/10.3233/JAD-180785 PMID: 30775981; PubMed Central
PMCID: PMC6443418.
PLOS ONE Lifetime experience and physical activity in exceptional aging
PLOSONE | https://doi.org/10.1371/journal.pone.0247225 February 19, 2021 22 / 23
106. Anaturk M, Demnitz N, Ebmeier KP, Sexton CE. A systematic review and meta-analysis of structural
magnetic resonance imaging studies investigating cognitive and social activity levels in older adults.
Neuroscience and biobehavioral reviews. 2018; 93:71–84. Epub 2018/06/26. https://doi.org/10.1016/j.
neubiorev.2018.06.012 PMID: 29940239; PubMed Central PMCID: PMC6562200.
107. Forstmeier S, Maercker A. Motivational processes in mild cognitive impairment and Alzheimer’s dis-
ease: results from the Motivational Reserve in Alzheimer’s (MoReA) study. BMC psychiatry. 2015;
15:293. Epub 2015/11/19. https://doi.org/10.1186/s12888-015-0666-8 PMID: 26578083; PubMed
Central PMCID: PMC4650956.
108. Forstmeier S, Maercker A, Maier W, van den Bussche H, Riedel-Heller S, Kaduszkiewicz H, et al.
Motivational reserve: motivation-related occupational abilities and risk of mild cognitive impairment
and Alzheimer disease. Psychology and aging. 2012; 27(2):353–63. Epub 2011/08/31. https://doi.org/
10.1037/a0025117 PMID: 21875213.
109. ThomaMV, Forstmeier S, Schmid R, Kellner O, Xepapadakos F, Gasser US, et al. Preliminary evi-
dence for an increased likelihood of a stable trajectory in mild cognitive impairment in individuals with
higher motivational abilities. BMC geriatrics. 2018; 18(1):181. Epub 2018/08/15. https://doi.org/10.
1186/s12877-018-0865-5 PMID: 30103681; PubMed Central PMCID: PMC6090725.
110. Jung YH, Park S, Jang H, Cho SH, Kim SJ, Kim JP, et al. Frontal-executive dysfunction affects demen-
tia conversion in patients with amnestic mild cognitive impairment. Sci Rep. 2020; 10(1):772. Epub
2020/01/23. https://doi.org/10.1038/s41598-020-57525-6 PMID: 31964931; PubMed Central PMCID:
PMC6972894.
111. Kohler S, Black SE, Sinden M, Szekely C, Kidron D, Parker JL, et al. Memory impairments associated
with hippocampal versus parahippocampal-gyrus atrophy: an MR volumetry study in Alzheimer’s dis-
ease. Neuropsychologia. 1998; 36(9):901–14. Epub 1998/09/18. https://doi.org/10.1016/s0028-3932
(98)00017-7 PMID: 9740363.
112. ChantomeM, Perruchet P., Hasboun D., Dormont D., Sahel M., Sourour N., et al. Is there a negative
correlation between explicit memory and hippocampal volume? Neuroimage. 1999;(10):589–95.
113. Foster JK, Meikler A., Goodson G., Mayes A.R., Howard M., Sunram S.I., et al. The hippocampus and
delayed recall: Bigger is not necessarily better? Memory. 1999; 7(5–6):715–33. https://doi.org/10.
1080/096582199387823 PMID: 10659094
114. Zhao Y, Tudorascu DL, Lopez OL, Cohen AD, Mathis CA, Aizenstein HJ, et al. Amyloid beta Deposi-
tion and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in
Oldest Old ParticipantsWithout Dementia. JAMA Neurol. 2018; 75(1):88–96. https://doi.org/10.1001/
jamaneurol.2017.3029 PMID: 29114732; PubMed Central PMCID: PMC5833487.
115. Berlau DJ, CorradaMM, Robinson JL, Geser F, Arnold SE, Lee VM, et al. Neocortical beta-amyloid
area is associated with dementia and APOE in the oldest-old. Alzheimers Dement. 2013; 9(6):699–
705. https://doi.org/10.1016/j.jalz.2012.11.011 PMID: 23474043; PubMed Central PMCID:
PMC3971646.
116. Kawas CH, Corrada MM. Alzheimer’s and dementia in the oldest-old: a century of challenges. Curr
Alzheimer Res. 2006; 3(5):411–9. https://doi.org/10.2174/156720506779025233 PMID: 17168640;
PubMed Central PMCID: PMC3373256.
117. Sobel E, Louhija J, Sulkava R, Davanipour Z, Kontula K, Miettinen H, et al. Lack of association of apoli-
poprotein E allele epsilon 4 with late-onset Alzheimer’s disease among Finnish centenarians. Neurol-
ogy. 1995; 45(5):903–7. https://doi.org/10.1212/wnl.45.5.903 PMID: 7746404.
118. Althouse AD. Adjust for Multiple Comparisons? It’s Not That Simple. Ann Thorac Surg. 2016; 101
(5):1644–5. https://doi.org/10.1016/j.athoracsur.2015.11.024 PMID: 27106412.
PLOS ONE Lifetime experience and physical activity in exceptional aging
PLOSONE | https://doi.org/10.1371/journal.pone.0247225 February 19, 2021 23 / 23
